Ralph Theo Schermuly Selected Research

Biomarkers (Surrogate Marker)

5/2023	Osteopontin in Pulmonary Hypertension.
1/2017	Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ralph Theo Schermuly Research Topics

Disease

43	Pulmonary Hypertension 05/2023 - 04/2002
21	Vascular Remodeling 05/2023 - 04/2004
20	Pulmonary Arterial Hypertension 05/2024 - 04/2002
20	Hypoxia (Hypoxemia) 06/2020 - 03/2003
10	Fibrosis (Cirrhosis) 01/2023 - 11/2009
9	Cardiomegaly (Heart Hypertrophy) 01/2019 - 04/2004
7	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023 - 10/2008
6	Familial Primary Pulmonary Hypertension 05/2024 - 07/2005
6	Neoplasms (Cancer) 01/2010 - 08/2005
4	Right Ventricular Hypertrophy 01/2021 - 01/2010
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 03/2011
4	Hypertrophy 01/2018 - 08/2007
3	Inflammation (Inflammations) 05/2023 - 04/2006
3	Lung Neoplasms (Lung Cancer) 09/2021 - 11/2009
3	COVID-19 08/2021 - 01/2021
3	Pulmonary Heart Disease (Cor Pulmonale) 03/2021 - 04/2004
3	Emphysema 01/2019 - 03/2011
3	Body Weight (Weight, Body) 12/2018 - 06/2012
3	Heart Failure 08/2016 - 01/2015
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 08/2021 - 01/2021
2	Heart Diseases (Heart Disease) 01/2020 - 08/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2015 - 01/2012
2	Lung Diseases (Lung Disease) 03/2014 - 11/2009
2	Idiopathic Pulmonary Fibrosis 01/2013 - 06/2011
2	Carcinoma (Carcinomatosis) 06/2007 - 03/2006
2	Hypotension (Low Blood Pressure) 04/2006 - 04/2006
1	Hyperemia 02/2024
1	Ventricular Remodeling 05/2023
1	Pulmonary edema of mountaineers 10/2021
1	Neoplasm Metastasis (Metastasis) 09/2021
1	Heart Neoplasms 01/2019

Drug/Important Bio-Agent (IBA)

15	MonocrotalineIBA 06/2020 - 04/2004
10	Iloprost (Ventavis)FDA Link 01/2021 - 04/2002
10	Sildenafil Citrate (Viagra)FDA Link 01/2018 - 04/2002
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2015 - 03/2003
7	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2015 - 04/2004
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2005
6	Soluble Guanylyl CyclaseIBA 01/2018 - 01/2006
5	Semaxinib (SU5416)IBA 01/2019 - 01/2012
5	CollagenIBA 01/2018 - 11/2009
5	Imatinib Mesylate (Gleevec)FDA Link 01/2013 - 10/2005
4	Oxygen (Dioxygen)IBA 12/2018 - 08/2005
4	Phosphodiesterase 5 InhibitorsIBA 01/2018 - 10/2007
3	Transcription Factors (Transcription Factor)IBA 10/2022 - 08/2005
3	Vasodilator Agents (Vasodilators)IBA 03/2020 - 04/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 08/2005
3	Fibronectins (Fibronectin)IBA 01/2018 - 11/2009
3	riociguatIBA 01/2018 - 01/2012
3	Messenger RNA (mRNA)IBA 01/2018 - 08/2007
3	CytokinesIBA 11/2017 - 03/2006
3	Chymases (Chymase)IBA 10/2015 - 01/2013
3	Bleomycin (Blenoxane)FDA LinkGeneric 10/2015 - 11/2010
3	Platelet-Derived Growth FactorIBA 06/2012 - 01/2010
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 06/2012 - 10/2005
3	diethylstilbestrol monophosphate (PDES)IBA 02/2012 - 01/2010
3	tolafentrineIBA 03/2011 - 04/2004
3	treprostinil FDA Link 02/2009 - 10/2006
3	ProstaglandinsIBA 02/2009 - 07/2005
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 10/2007 - 04/2002
2	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2017
2	Surface-Active Agents (Surfactants)IBA 01/2023 - 08/2021
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2018 - 01/2012
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2018 - 11/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 09/2013
2	dironyl (terguride)IBA 01/2015 - 11/2010
2	SmokeIBA 01/2015 - 03/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2013 - 11/2009
2	Small Interfering RNA (siRNA)IBA 09/2013 - 04/2011
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2013 - 06/2011
2	dimethylargininaseIBA 01/2013 - 06/2011
2	Becaplermin (PDGF-BB)FDA Link 01/2013 - 04/2012
2	Phosphodiesterase InhibitorsIBA 01/2010 - 07/2005
2	Protein Isoforms (Isoforms)IBA 01/2010 - 11/2009
2	Vasoconstrictor AgentsIBA 10/2007 - 04/2006
2	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA 01/2006 - 07/2005
2	ThromboxanesIBA 01/2006 - 07/2005
1	Insulin-Like Growth Factor Binding Protein 3IBA 05/2024
1	Insulin-Like Growth Factor Binding ProteinsIBA 05/2024
1	Insulin-Like Growth Factor Binding Protein 1IBA 05/2024
1	Insulin-Like Growth Factor Binding Protein 2IBA 05/2024
1	salicylhydroxamic acid (SHAM)IBA 02/2024
1	OsteopontinIBA 05/2023
1	IntegrinsIBA 05/2023
1	Indicators and Reagents (Reagents)IBA 05/2023
1	Janus KinasesIBA 01/2023
1	Adenylate KinaseIBA 09/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2021
1	Chemokine ReceptorsIBA 01/2021
1	ruxolitinibIBA 01/2021
1	ChemokinesIBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	palbociclibIBA 01/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019
1	6-chloropenicillanic acid S-sulfoxideIBA 01/2019
1	Atrial Natriuretic Factor (ANF)IBA 01/2018
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2016

Therapy/Procedure

19	Therapeutics 05/2023 - 04/2002
2	Cardiac Catheters 02/2009 - 10/2008
2	Immunotherapy 06/2007 - 03/2006
1	Noninvasive Ventilation 08/2021